Various pharmaceutical companies have settled with the U.S. government for their improper use of charities to pay kickbacks to Medicare enrollees to boost sales of their medications. These companies are accused of using these charities to cover enrollees’ out-of-pocket expenses. The pharmaceutical companies accused of this scheme are: Actelion, Alexion, Jazz Pharmaceuticals, Lundbeck, Novartis, Pfizer...Read More

Warner Chilcott is the company that plead guilty to violating the Anti-Kickback Statute and promoting their drugs for off label usage. The drugs in question are Actonel, Atelvia, Asacol HD, Doryx, Enablex, Estrace Cream, Loestrin and Lo-Loestrin. Its sales team would promote their medications as clinically superior to their competitor drugs and induce healthcare professionals...Read More

Warning issued on rheumatoid arthritis drug, Xelianz. Pfizer drug, Xeljanz, used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis, is under question for causing blood clots in the lungs that also lead to death. European regulators have ceased the high dosage of the medication while the U.S. Food and Drug Administration (FDA) still believes...Read More

Get the Facts The drug manufacturer, Reckitt Benckiser, has agreed to pay the U.S. government $1.4 billion to settle allegations that it downplayed the risk of addiction of its medication Suboxone. The Department of Justice states that the British manufacturer marketed their drug as a less addictive drug and safer than ones that were on...Read More

A complaint has been filed against Novartis AG accusing the pharmaceutical giant of paying illegal kickbacks to healthcare professionals. Novartis AG will now face trial against the U.S. government as it is under fire for paying millions of dollars illegally to doctors as kickbacks to induce them to prescribe its drugs. This is not the...Read More

Teva Pharmaceuticals along with several other manufacturers are at the center of a lawsuit filed by Connecticut’s State Attorney General and the Attorney General of 44 additional states offices accusing the pharmaceutical companies of unlawfully inflating their drugs’ prices. This complaint was filed on May 10, 2019 against the top names in the pharmaceutical industry:...Read More

Allergan, the maker of the ulcerative colitis medication Asacol, is seeking to end a class action complaint filed by Asacol purchasers alleging that the manufacturer unlawfully delayed a generic version of the drug from entering the market. Allergan, a subsidiary of Warner Chilcott Ltd, is accused of replacing its patent expired medication with a newer...Read More

A class action complaint filed in the Northern District of California alleges that Gilead Sciences, Inc. (Gilead) amassed an HIV drug empire by entering into anti-competitive agreements with other pharmaceutical companies including Bristol-Myers Squibb, Janssen Pharmaceuticals and Japan Tobacco in order to prohibit them from releasing into the market their generic versions of Gilead’s tenofovir...Read More

Purdue Pharma agreed to pay $270 million to the Oklahoma state attorney general on March 26, 2019 for its painkiller medication, OxyContin, for aggressively marketing its drug that led to an epidemic of deaths in the state. The settlement includes money that will establish addiction treatment and research centers and money that will go directly...Read More

Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. Ltd. have reached a confidential settlement regarding the drug Abilify with plaintiffs in the multi district litigation (MDL) on February 26, 2019. The drug is meant for antipsychotic purposes to treat schizophrenia and bipolar disorders. However, Abilify has also been known to cause side effects of compulsive behaviors,...Read More